{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:56:07Z","timestamp":1772006167674,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,1,20]],"date-time":"2015-01-20T00:00:00Z","timestamp":1421712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s12272-015-0560-4","type":"journal-article","created":{"date-parts":[[2015,1,19]],"date-time":"2015-01-19T15:21:59Z","timestamp":1421680919000},"page":"1019-1032","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Discovery of 4-(phenyl)thio-1H-pyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor"],"prefix":"10.1007","volume":"38","author":[{"given":"Hyeon Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vithal B.","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Young","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Hwan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunkyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heeyeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,20]]},"reference":[{"key":"560_CR1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0003-9861(55)90070-9","volume":"54","author":"R Altschul","year":"1955","unstructured":"Altschul, R., A. Hoffer, and J.D. Stephen. 1955. Influence of nicotinic acid on serum cholesterol in man. Archives of Biochemistry and Biophysics 54: 558\u2013559.","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"560_CR2","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.1172\/JCI23626","volume":"115","author":"Z Benyo","year":"2005","unstructured":"Benyo, Z., A. Gille, J. Kero, M. Csiky, M.C. Suchankova, R.M. Nusing, A. Moers, K. Pfeffer, and S. Offermanns. 2005. GPR109A (PUMA-G\/HM74A) mediates nicotinic acid-induced flushing. Journal of Clinical Investigation 115: 3634\u20133640.","journal-title":"Journal of Clinical Investigation"},{"key":"560_CR3","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1021\/jm2010964","volume":"55","author":"PD Boatman","year":"2012","unstructured":"Boatman, P.D., B. Lauring, T.O. Schrader, M. Kasem, B.R. Johnson, P. Skinner, J.-K. Jung, J. Xu, M.C. Cherrier, P.J. Webb, G. Semple, C.R. Sage, J. Knudsen, R. Chen, W.-L. Luo, L. Caro, J. Cote, E. Lai, J. Wagner, A.K. Taggart, E. Carballo-Jane, M. Hammond, S.L. Colletti, J.R. Connolly, M.G. Waters, and J.G. Richman. 2012. (1aR,5aR)1a,3,5,5a-Tetrahydro-1H-diaza-cyclopropa[a]pentalene-4-carboxylic acid (MK-1903): A potent GPR109A agonist that lowers free fatty acids in humans. Journal of Medicinal Chemistry 55: 3644\u20133666.","journal-title":"Journal of Medicinal Chemistry"},{"key":"560_CR4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2796.2005.01528.x","volume":"258","author":"LA Carlson","year":"2005","unstructured":"Carlson, L.A. 2005. Nicotinic acid: The broad-spectrum lipid drug. A 50th anniversary review. Journal of Internal Medicine 258: 94\u2013114.","journal-title":"Journal of Internal Medicine"},{"key":"560_CR5","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1016\/j.bmcl.2008.08.030","volume":"18","author":"Q Deng","year":"2008","unstructured":"Deng, Q., J.L. Frie, D.M. Marley, R.T. Beresis, N. Ren, T.-Q. Cai, A.K.P. Taggart, K. Cheng, E. Carballo-Jane, J. Wang, X. Tong, M.G. Waters, J.R. Tata, and S.L. Colletti. 2008. Molecular modeling aided design of nicotinic acid receptor GPR109A agonists. Bioorganic and Medicinal Chemistry Letters 18: 4963\u20134967.","journal-title":"Bioorganic and Medicinal Chemistry Letters"},{"key":"560_CR6","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1172\/JCI106122","volume":"48","author":"RP Eaton","year":"1969","unstructured":"Eaton, R.P., M. Berman, and D. Steinberg. 1969. Kinetic studies of plasma free fatty acid and triglyceride metabolism in man. Journal of Clinical Investigation 48: 1560\u20131579.","journal-title":"Journal of Clinical Investigation"},{"key":"560_CR7","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2013.06.008","volume":"25","author":"I Gaidarov","year":"2013","unstructured":"Gaidarov, I., X. Chen, T. Anthony, D. Maciejewski-Lenoir, C. Liaw, and D.J. Unett. 2013. Differential tissue and ligand-dependent signaling of GPR109A receptor: Implications for anti-atherosclerotic therapeutic potential. Cellular Signaling 25: 2003\u20132016.","journal-title":"Cellular Signaling"},{"key":"560_CR8","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1194\/jlr.M300403-JLR200","volume":"45","author":"SH Ganji","year":"2004","unstructured":"Ganji, S.H., S. Tavintharan, D. Zhu, Y. Xing, V.S. Kamanna, and M.L. Kashyap. 2004. Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells. Journal of Lipid Research 45: 1835\u20131845.","journal-title":"Journal of Lipid Research"},{"key":"560_CR9","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1172\/JCI42273","volume":"120","author":"J Hanson","year":"2010","unstructured":"Hanson, J., A. Gille, S. Zwykiel, M. Lukasova, B.E. Clausen, K. Ahmed, S. Tunaru, A. Wirth, and S. Offermanns. 2010. Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice. Journal of Clinical Investigation 120: 2910\u20132919.","journal-title":"Journal of Clinical Investigation"},{"key":"560_CR10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/jm070022x","volume":"50","author":"J-K Jung","year":"2007","unstructured":"Jung, J.-K., B.R. Johnson, T. Duong, M. Decaire, J. Uy, T. Gharbaoui, P.D. Boatman, C.R. Sage, R. Chen, J.G. Richman, D.T. Connolly, and G. Semple. 2007. Analogues of acifran: Agonists of the high and low affinity niacin receptors, GPR109a and GPR109b. Journal of Medicinal Chemistry 50: 1445\u20131448.","journal-title":"Journal of Medicinal Chemistry"},{"key":"560_CR11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0003-2697(02)00587-0","volume":"314","author":"P Kunapuli","year":"2003","unstructured":"Kunapuli, P., R. Ransom, K.L. Murphy, D. Pettibone, J. Kerby, S. Grimwood, P. Zuck, P. Hodder, R. Lacson, I. Hoffman, J. Inglese, and B. Strulovici. 2003. Development of an intact cell reporter gene beta-lactamase assay for G protein-coupled receptors for high-throughput screening. Analytical Biochemistry 314: 16\u201329.","journal-title":"Analytical Biochemistry"},{"key":"560_CR12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jacl.2008.08.445","volume":"2","author":"E Lai","year":"2008","unstructured":"Lai, E., M.G. Waters, J.R. Tata, W. Radziszewski, I. Perevozskaya, W. Zheng, L. Wenning, D.T. Connolly, G. Semple, A.O. Johnson-Levonas, J.A. Wagner, Y. Mitchel, and J.F. Paolini. 2008. Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans. Journal of Clinical Lipidology 2: 375\u2013383.","journal-title":"Journal of Clinical Lipidology"},{"key":"560_CR13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pharmthera.2003.10.001","volume":"101","author":"W Goff Le","year":"2004","unstructured":"Le Goff, W., M. Guerin, and M.J. Chapman. 2004. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia. Pharmacology and Therapeutics 101: 17\u201338.","journal-title":"Pharmacology and Therapeutics"},{"key":"560_CR14","doi-asserted-by":"crossref","first-page":"22605","DOI":"10.1074\/jbc.M109.087213","volume":"285","author":"G Li","year":"2010","unstructured":"Li, G., Y. Shi, H. Huang, Y. Zhang, K. Wu, J. Luo, Y. Sun, J. Lu, J.L. Benovic, and N. Zhou. 2010. Internalization of the human nicotinic acid receptor GPR109A is regulated by G(i), GRK2, and arrestin3. Journal of Biological Chemistry 285: 22605\u201322618.","journal-title":"Journal of Biological Chemistry"},{"key":"560_CR15","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1016\/j.tet.2008.02.010","volume":"64","author":"AR Muhammad","year":"2008","unstructured":"Muhammad, A.R., N. Rasool, M. Adeel, H. Reinke, C. Fischer, and P. Langer. 2008. Synthesis and functionalized diaryl sulfides based on regioselective one-pot cyclization of 1,3-bis(trimethylsilyloxy)-1,3-butadienes. Tetrahedron 64: 3782\u20133793.","journal-title":"Tetrahedron"},{"key":"560_CR16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tips.2006.05.008","volume":"27","author":"S Offermanns","year":"2006","unstructured":"Offermanns, S. 2006. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target. Trends in Pharmacological Sciences 27: 384\u2013390.","journal-title":"Trends in Pharmacological Sciences"},{"key":"560_CR17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1021\/ml200243g","volume":"3","author":"A Palani","year":"2012","unstructured":"Palani, A., A.U. Rao, X. Chen, X. Huang, J. Su, H. Tang, Y. Huang, J. Qin, D. Xiao, S. Degrado, M. Sofolarides, X. Zhu, Z. Liu, B. Mckittrick, W. Zhou, R. Aslania, W.J. Greenlee, M. Senior, B. Cheewatrakoolpong, H. Zhang, C. Farley, J. Cook, S. Kurowski, Q. Li, M. Heek, G. Wang, Y. Hsieh, F. Li, S. Greenfeder, and M. Chintala. 2012. Discovery of SCH 900271, a potent nicotinic acid receptor agonist for the treatment of dyslipidemia. ACS Medicinal Chemistry Letters 3: 63\u201368.","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"560_CR18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archinte.1959.00270050105016","volume":"103","author":"WB Parsons Jr","year":"1959","unstructured":"Parsons Jr., W.B., and J.H. Flinn. 1959. Reduction of serum cholesterol levels and beta-lipoprotein cholesterol levels by nicotinic acid. AMA Archives of Internal Medicine 103: 783\u2013790.","journal-title":"AMA Archives of Internal Medicine"},{"key":"560_CR19","doi-asserted-by":"crossref","first-page":"18028","DOI":"10.1074\/jbc.M701866200","volume":"282","author":"JG Richman","year":"2007","unstructured":"Richman, J.G., M. Kanemitsu-Parks, I. Gaidarov, J.S. Cameron, P. Griffin, H. Zheng, N.C. Guerra, L. Cham, D. Maciejewski-Lenoir, D.P. Behan, D. Boatman, R. Chen, P. Skinner, P. Ornelas, M.G. Waters, S.D. Wright, G. Semple, and D.T. Connolly. 2007. Nicotinic acid receptor agonists differentially activate downstream effectors. Journal of Biological Chemistry 282: 18028\u201318036.","journal-title":"Journal of Biological Chemistry"},{"key":"560_CR20","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1021\/jm100022r","volume":"53","author":"HC Shen","year":"2010","unstructured":"Shen, H.C., F.X. Ding, S. Raghavan, Q. Deng, S. Luell, M.J. Forrest, E. Carballo-Jane, L.C. Wilsie, M.L. Krsmanovic, A.K. Taggart, K.K. Wu, T.J. Wu, K. Cheng, N. Ren, T.Q. Cai, Q. Chen, J. Wang, M.S. Wolff, X. Tong, T.G. Holt, M.G. Waters, M.L. Hammond, J.R. Tata, and S.L. Colletti. 2010. Discovery of a biaryl cyclohexene carboxylic acid (MK-6892): A potent and selective high affinity niacin receptor full agonist with reduced flushing profiles in animals as a preclinical candidate. Journal of Medicinal Chemistry 53: 2666\u20132670.","journal-title":"Journal of Medicinal Chemistry"},{"key":"560_CR21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0006-291X(03)00342-5","volume":"303","author":"T Soga","year":"2003","unstructured":"Soga, T., M. Kamohara, J. Takasaki, S. Matsumoto, T. Saito, T. Ohishi, H. Hiyama, A. Matsuo, H. Matsushime, and K. Furuichi. 2003. Molecular identification of nicotinic acid receptor. Biochemical and Biophysical Research Communications 303: 364\u2013369.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"560_CR22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/med.20102","volume":"27","author":"W Soudijn","year":"2007","unstructured":"Soudijn, W., I. Wijngaarden, and A.P. Izerman. 2007. Nicotinic acid receptor subtypes and their ligands. Medicinal Research Reviews 27: 417\u2013433.","journal-title":"Medicinal Research Reviews"},{"key":"560_CR23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nm824","volume":"9","author":"S Tunaru","year":"2003","unstructured":"Tunaru, S., J. Kero, A. Schaub, C. Wufka, A. Blaukat, K. Pfeffer, and S. Offermanns. 2003. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nature Medicine 9: 352\u2013355.","journal-title":"Nature Medicine"},{"key":"560_CR24","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1172\/JCI36806","volume":"119","author":"RW Walters","year":"2009","unstructured":"Walters, R.W., A.K. Shukla, J.J. Kovacs, J.D. Violin, S.M. DeWire, C.M. Lam, J.R. Chen, M.J. Muehlbauer, E.J. Whalen, and R.J. Lefkowitz. 2009. Beta-arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. Journal of Clinical Investigation 119: 1312\u20131321.","journal-title":"Journal of Clinical Investigation"},{"key":"560_CR25","doi-asserted-by":"crossref","first-page":"9869","DOI":"10.1074\/jbc.M210695200","volume":"278","author":"A Wise","year":"2003","unstructured":"Wise, A., S.M. Foord, N.J. Fraser, A.A. Barnes, N. Elshourbagy, M. Eilert, D.M.P. Ignar, R. Murdock, K. Steplewski, A. Green, A.J. Brown, S.J. Dowell, P.G. Szekeres, D.G. Hassall, F.H. Marshall, S. Wilson, and N.B. Pike. 2003. Molecular identification of high and low affinity receptors for nicotinic acid. Journal of Biological Chemistry 278: 9869\u20139874.","journal-title":"Journal of Biological Chemistry"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-015-0560-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-015-0560-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-015-0560-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T06:57:42Z","timestamp":1559458662000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-015-0560-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,20]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["560"],"URL":"https:\/\/doi.org\/10.1007\/s12272-015-0560-4","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,20]]}}}